Examination of the Rate and Extent of Drug Released from Commercial Topical Delivery Systems During Wear: An Example with Lidocaine Topical Systems-Reference-Cited by-同舟云学术

Examination of the Rate and Extent of Drug Released from Commercial Topical Delivery Systems During Wear: An Example with Lidocaine Topical Systems

Published:2023-10-17 Issue:1 Volume:41 Page:39-50
ISSN:0724-8741
Container-title:Pharmaceutical Research
language:en
Short-container-title:Pharm Res

Author:

Cai Qing,Azarpanah Armita,Bhatt Jayshil A.,Wei Hui,Carr Jamie,Morris Kenneth R.,Strasinger Caroline,Brogden Nicole K.^ORCID

Funder

National Institute for Pharmaceutical Technology and Education

The National Institutes of Health

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s11095-023-03617-7.pdf

Reference18 articles.

1. Transdermal and topical delivery systems - product development and quality considerations. Draft guidance for industry. 2019:1–25. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/transdermal-and-topical-deliverysystems-product-development-and-quality-considerations. Accessed 9 Oct 2023.

2. Swaminathan SK, Strasinger C, Kelchen M, Carr J, Ye W, Wokovich A, et al. Determination of Rate and Extent of Scopolamine Release from Transderm Scōp® Transdermal Drug Delivery Systems in Healthy Human Adults. AAPS PharmSciTech. 2020;21(3):117.

3. Lidoderm® package insert. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020612s012lbl.pdf. Accessed 21 Aug 2023.

4. ZTLIDO package insert. https://www.ztlido.com/wp-content/uploads/2022/12/ZTlido-LABEL.pdf. Accessed 21 Aug 2023.

5. Lidocaine patch 5% package insert. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5c66f3b9-6e04-47ab-8d94-21e89ceec154. Accessed 21 Aug 2023.